Wayne Jones
Psychiatry · Richardson, TXNPI 1457470528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 212 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 10.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,703 and has fallen 97.5% since, to $42 in 2023.
Across 212 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$437
- Ironshore Pharmaceuticals Inc.$413
- Jazz Pharmaceuticals Inc.$361
- Johnson & Johnson$356
- Takeda Pharmaceuticals U.S.A., Inc.$334
- AbbVie$315
- plus $2K from 23 others
What the payments were for
- Food & beverage$3,999100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 7 | $437 |
| Ironshore Pharmaceuticals Inc. | 24 | $413 |
| Jazz Pharmaceuticals Inc. | 11 | $361 |
| Johnson & Johnson | 12 | $356 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $334 |
| AbbVie(2 entities) | 14 | $315 |
| Avanir Pharmaceuticals, Inc. | 14 | $246 |
| Arbor Pharmaceuticals, Inc. | 36 | $197 |
| Eisai Inc. | 10 | $197 |
| Validus Pharmaceuticals LLC | 3 | $159 |
| Bausch Health US, LLC | 11 | $157 |
| Otsuka America Pharmaceutical, Inc. | 8 | $128 |
| Neos Therapeutics, LP | 6 | $108 |
| Merck | 6 | $94 |
| Shire North American Group Inc | 4 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $64 |
| Almatica Pharma LLC | 4 | $61 |
| Corium, LLC | 3 | $58 |
| Aytu Biopharma, Inc. | 3 | $49 |
| Acerus Pharmaceuticals Corporation | 3 | $42 |
| Adlon Therapeutics L.p. | 2 | $38 |
| Harmony Biosciences LLC | 1 | $19 |
| Antares Pharma, Inc. | 1 | $17 |
| Noven Therapeutics, LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
| IBSA Pharma Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,999 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Richardson
- Thomas ShoafRichardson$44K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
- Frank ChenHouston$941K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.